Optima Capital »

Fennec Pharmaceuticals shares owned by Optima Capital

Quarter-by-quarter ownership of Fennec Pharmaceuticals (FENC) shares owned by Optima Capital from 13F filings

Historical chart of Optima Capital investment in Fennec Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Fennec Pharmaceuticals held by Optima Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fennec Pharmaceuticals by Optima Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $484 63 7.70

More positions owned by Optima Capital

Spdr Series Trust State Street Spd (SPYM)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
Vanguard Index Fds Total Stk Mkt (VTI)
J P Morgan Exchange Traded F Income Etf (JPIE)
Doubleline Etf Trust Opportunistic Co (DBND)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
J P Morgan Exchange Traded F Active Bond Etf (JBND)
Ishares Tr Core Msci Eafe (IEFA)
Cambria Etf Tr Global Value Etf (GVAL)
Wisdomtree Tr Yield Enhancd Us (AGGY)
Ishares Tr Msci Usa Quality (GARP)
Dimensional Etf Trust Intl Core Eqt Mk (DFAI)
Vanguard Specialized Funds Div App Etf (VIG)
Wisdomtree Tr Wisdomtree Us Va (WTV)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)

View all positions for Optima Capital

Top funds holding Fennec Pharmaceuticals

Southpoint Capital Advisors
Rosalind Advisors
Solas Capital Management
AIGH Capital Management
BlackRock
Vanguard Group
AWM Investment Company
State Street Corporation
Geode Capital Management
Apis Capital Advisors
Jeffrey L. Gendell
Marshall Wace
Lion Point Capital
Northern Trust
Citadel Advisors

View all funds holding Fennec Pharmaceuticals